| let-7a |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| let-7b |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-1 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
Low |
25142144 |
|
| miR-1181 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
Low |
25142144 |
|
| miR-1246 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-1290 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
Low |
25142144 |
|
| miR-130b |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-135a |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
Low |
25142144 |
|
| miR-139 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-144 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
Low |
25142144 |
|
| miR-1471 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-150 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-181c |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-186 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-18a |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-18b |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-193a |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-195 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-196b |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
Low |
25142144 |
|
| miR-23b |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-24 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-26a |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-27b |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-29c |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-3065 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-30c |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-30e |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-31 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
Low |
25142144 |
|
| miR-3137 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-3195 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-3198 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-328 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-331 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-34a |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-34b |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
Low |
25142144 |
|
| miR-34b |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-361 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-3648 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-3663 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-3667 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-3926 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-3934 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-4271 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-4291 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-4327 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-449a |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
Low |
25142144 |
|
| miR-483 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-497 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-500a |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
High |
25142144 |
|
| miR-598 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
Low |
25142144 |
|
| miR-628 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Resistant |
Low |
25142144 |
|
| miR-630 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-642b |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-663a |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|
| miR-7 |
platinum-based doublet chemotherapy |
lung adenocarcinoma |
Sensitive |
High |
25142144 |
|